Morning Break: $600K Gene Therapy; Selling Surgery; Brain-Eating Amoeba

The price tag on gene therapy for 'bubble boy' disease? $665,000.

These volunteer drug researchers make sure that ecstasy is ecstatic. (NPR)

Banner Health says hackers may have gained access to patient data. (Reuters)

Half of all pediatric clinical trials registered at ClinicalTrials.gov don't make it to publication. (Pediatrics via STAT) See Perry Wilson's take on this in 150 Second Analysis.

Government researchers have started the first trial of a Zika vaccine. (Reuters)

The New York Attorney General is trying to shut down companies that are marketing unproven Zika protection products. (Reuters)

And a total of 41 U.S. military members have been diagnosed with Zika since testing began earlier this year. (CNN)

CVS is nixing 131 drugs from its coverage plans for 2017, steering customers toward cheaper generics. (Drug Discovery & Development)

This won't shock anyone who has spent time on a surgical rotation, but PLOS ONE provides details, details, details on surgical salespeople (detailers) who are side-by-side with surgeons in the OR. (via STAT)

A South Carolina resident has been hospitalized after contracting a brain-eating amoeba. (ABC News)

Here's how one doc is improving healthcare for the LGBTQ community. (KevinMD)

There may soon be another physician in Congress: Roger Marshall, MD, an OB/GYN from Great Bend, Kan., defeated incumbent Dave Huelskamp in the Republican primary in the state's 1st Congressional district; no Democrats are running for the seat although one independent is expected to run. (The New York Times)

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.

Let's block ads! (Why?)

Morning Break: $600K Gene Therapy; Selling Surgery; Brain-Eating Amoeba